Kissei Pharmaceutical

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 10, 2020	CG Oncology	$47.0M Series D	Mutsuo Kanzawa	Camford Capital, ORI Healthcare Fund, Perseverance Capital Management

Total Raised

N/A

Valuation

N/A

Key people at Kissei Pharmaceutical.

Mutsuo Kanzawa

Key people at Kissei Pharmaceutical.

Mutsuo Kanzawa